Patents by Inventor Michael Cancro

Michael Cancro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF B LYMPHOCYTE STIMULATOR PROTEIN ANTAGONISTS TO PROMOTE TRANSPLANTATION TOLERANCE
    Publication number: 20160311914
    Abstract: The invention relates to methods of preventing, treating, ameliorating and otherwise inhibiting organ or transplant rejection in a patient by administering B Lymphocyte Stimulator antagonists. In addition, therapeutic treatment regimens are provided to promote transplant tolerance in a patient following the administration of B Lymphocyte Stimulatorantagonists.
    Type: Application
    Filed: May 17, 2016
    Publication date: October 27, 2016
    Inventors: Thi-Sau MIGONE, Hooman Noorchashm, Michael Cancro
  • USE OF B LYMPHOCYTE STIMULATOR PROTEIN ANTAGONISTS TO PROMOTE TRANSPLANTATION TOLERANCE
    Publication number: 20150322158
    Abstract: The invention relates to methods of preventing, treating, ameliorating and otherwise inhibiting organ or transplant rejection in a patient by administering B Lymphocyte Stimulator antagonists. In addition, therapeutic treatment regimens are provided to promote transplant tolerance in a patient following the administration of B Lymphocyte Stimulatorantagonists.
    Type: Application
    Filed: May 5, 2015
    Publication date: November 12, 2015
    Inventors: Thi-Sau MIGONE, Hooman Noorchashm, Michael Cancro
  • USE OF B LYMPHOCYTE STIMULATOR PROTEIN ANTAGONISTS TO PROMOTE TRANSPLANTATION TOLERANCE
    Publication number: 20110014190
    Abstract: The invention relates to methods of preventing, treating, ameliorating and otherwise inhibiting organ or transplant rejection in a patient by administering B Lymphocyte Stimulator antagonists. In addition, therapeutic treatment regimens are provided to promote transplant tolerance in a patient following the administration of B Lymphocyte Stimulatorantagonists.
    Type: Application
    Filed: February 12, 2010
    Publication date: January 20, 2011
    Applicants: HUMAN GENOME SCIENCES, INC., THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
    Inventors: Thi-Sau Migone, Hooman Noorchashm, Michael Cancro